Gilead Sciences Inc.
- Price
- 129.31 USD
- Fair value
- 89.05 USD
- Discount to fair value
- −45%
- Mkt cap
- 160.55B
- P/E
- 18.9×
- P/B
- 7.07×
- EV
- 177.92B
- Div yield
- 2.49%
- ROE
- 37.5%
- Net margin
- 28.9%
Current price129.31USD
Fair value (est., median)89.05USD
UndervaluedFair valueOvervalued
+45.2% above fair valueWould need to fall ~31.1% to reach fair value.
Median ofDCF 396.34DDM 89.05Graham 48.9Residual Income 132.16Earnings Power 83.23
Health Check
51.4
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Strong return on equity (37.5%).
- Attractive, covered dividend (2.49%).
Risks
- Trades 45.2% above estimated fair value.
- Low fair-value confidence — methods disagree or data is thin.
- Expensive on book (P/B 7.1×).
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 19 years · FY2007–FY2025
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 27.30B | 27.28B | 27.12B | 28.75B | 29.44B |
| Net Income | 6.22B | 4.59B | 5.67B | 480.00M | 8.51B |
| Net Margin | 22.8% | 16.8% | 20.9% | 1.7% | 28.9% |
| Operating Cash Flow | 11.38B | 9.07B | 8.01B | 10.83B | 10.02B |
| OCF Margin | 41.7% | 33.3% | 29.5% | 37.7% | 34.0% |
| Capital Expenditure | 579.00M | 728.00M | 585.00M | 523.00M | 563.00M |
| Free Cash Flow | 10.80B | 8.34B | 7.42B | 10.30B | 9.46B |
| FCF Margin | 39.6% | 30.6% | 27.4% | 35.8% | 32.1% |
| FCF Conversion | 173.6% | 181.7% | 131.0% | 2,146.9% | 111.1% |
| EPS (Diluted) | 5.01/sh | 3.70/sh | 4.56/sh | 0.39/sh | 6.85/sh |
| Dividend / Share | 2.90/sh | 2.99/sh | 3.07/sh | 3.16/sh | 3.22/sh |
Dividend return (if you buy today)if you buy today
Dividend yield2.49%
Dividend / share3.22 USD
If you invest
USD
Shares (≈)77
Est. annual income248.26 USD
At this rate, dividends alone return your capital in ~40.1 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | 0.82 | 0.82 | — | — | 1.64 | 1.2% |
| 2025 | 0.79 | 0.79 | 0.79 | 0.79 | 3.22 | 2.9% |
| 2024 | 0.77 | 0.77 | 0.77 | 0.77 | 3.16 | 4.1% |
| 2023 | 0.75 | 0.75 | 0.75 | 0.75 | 3.07 | 3.9% |
| 2022 | 0.73 | 0.73 | 0.73 | 0.73 | 2.99 | 4.4% |
Corporate actions
DCash Dividend
0.82 USD /sh2026-06-15
DCash Dividend
0.82 USD /sh2026-03-13
DCash Dividend
0.79 USD /sh2025-12-15
DCash Dividend
0.79 USD /sh2025-09-15
DCash Dividend
0.79 USD /sh2025-06-13
DCash Dividend
0.79 USD /sh2025-03-14
DCash Dividend
0.77 USD /sh2024-12-13
DCash Dividend
0.77 USD /sh2024-09-13
DCash Dividend
0.77 USD /sh2024-06-14
DCash Dividend
0.77 USD /sh2024-03-14
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
396.34 USD
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
89.05 USD
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
48.90 USD
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
132.16 USD
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
83.23 USD
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)89.05 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 6.73%
- CAPM cost of equity
- 6.98%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Gilead Sciences Inc. regularly?
Starting year
- Invested
- 1K/yr · 35K total(1992 → today · 35 yrs)
- your value today is
- 2.3M USD
- Total return
- +6444.4%(+1207.2% Dividends · +5237.1% Capital gain)
- Annualised (IRR)
- +19.8%
Invested35KUSD
Dividends422.5KUSD
Capital gain1.8MUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.